ACIU
AC Immune Ltd
2.60$
-0.4%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +29.1% | -40.6% | -12.7% | -64.5% | +1,435.4% | -86.0% | -93.9% | +316.8% | +276.1% | +84.5% | -86.9% | |
| – | +5.8% | +51.2% | +26.7% | +35.6% | +13.9% | +18.0% | +4.7% | -3.1% | -9.5% | +14.6% | – | |
| – | +55.7% | -111.6% | – | – | – | -173.4% | – | – | -1,111.6% | – | – | |
| – | +5.8% | +51.2% | +26.7% | +35.6% | +13.9% | +18.0% | +4.7% | -3.1% | -9.5% | +14.6% | -9.8% | |
| – | +2.1% | +131.8% | +32.7% | +20.6% | +112.3% | +15.6% | -41.4% | -11.9% | +10.4% | +8.1% | +1.9% | |
| – | +4.7% | +64.5% | +27.1% | +32.6% | -72.7% | +11.1% | +359.3% | -5.4% | -81.5% | +23.9% | +323.2% | |
| – | +73.8% | -156.1% | – | – | – | -237.6% | – | – | – | – | – | |
| – | +550.0% | +884.6% | -42.6% | +127.2% | +476.6% | -90.4% | +215.8% | -38.9% | -50.4% | -24.4% | +43.6% | |
| – | +88.7% | -135.0% | – | – | – | -236.3% | – | – | – | – | – | |
| – | +5,200.0% | +120.1% | -95.9% | -850.3% | – | -90.3% | -98.4% | +333.3% | -23.1% | -70.0% | – | |
| – | +88.7% | -135.0% | – | – | – | -236.3% | – | – | – | – | – | |
| – | +71.7% | -136.0% | – | – | – | -230.4% | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.